dCBTi for Adults With ADHD
Primary Purpose
Insomnia
Status
Recruiting
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Sleep Hygiene and Self-Monitoring Control
dCBTi-ADHD
Sponsored by
About this trial
This is an interventional treatment trial for Insomnia focused on measuring Digital intervention, Cognitive Behavioral Therapy for Insomnia, Treatment efficacy, Treatment adherence
Eligibility Criteria
Inclusion Criteria:
- (a) Hong Kong resident,
- (b) Aged between 18-60,
- (c) Diagnosed with ADHD,
- (d) Able to read and write Chinese,
- (e) Has regular access to a smart phone and internet,
- (f) Insomnia severity index ⩾10
Exclusion Criteria:
- (a) Having comorbid bipolar disorder, psychosis, suicidality, moderately severe to severe depression, narcolepsy, and/or hypersomnolence disorder,
- (b) Having medical conditions that might affect sleep (e.g., serious physical concerns necessitating surgery, risk of falls, epilepsy),
- (c) Having night shift schedules at work,
- (d) Currently receiving psychological intervention for insomnia
Sites / Locations
- The University of Hong KongRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Digital Sleep Hygiene and Self-Monitoring Control
dCBTi-ADHD
Arm Description
Participants assigned to this condition will receive an app to track sleep and offers sleep hygiene recommendations
Participants assigned to this condition will receive a 7-module digital cognitive behavioral therapy for insomnia (dCBTi) tailored for adults with ADHD
Outcomes
Primary Outcome Measures
Changes in Insomnia Severity Index (ISI)
Insomnia symptoms measured by the Insomnia Severity Index (ISI). The score ranges from 0 to 24. Higher scores indicate greater levels of insomnia symptoms
Secondary Outcome Measures
Changes in total sleep time (TST)
Total sleep time (TST) measured by Consensus Sleep Diary. Its units is minutes. Higher TST indicates longer total sleep duration.
Changes in sleep efficiency (SE)
Sleep efficiency (SE) measured by Consensus Sleep Diary. It ranges from 0 to 100%, the higher indicates better sleep
Changes in sleep onset latency (SOL)
Sleep onset latency (SOL) measured by Consensus Sleep Diary. Its unit is minutes. Longer SOL indicates greater levels of insomnia
Changes in midsleep time (MST)
Midsleep time (MST) measured by Consensus Sleep Diary. Its unit is time. Earlier MST indicates earlier overall timing of sleep.
Changes in fatigue
Fatigue measured by the Fatigue Assessment Scale (FAS). The score ranges from 10 to 50, the higher the greater levels of fatigue
Changes in depressive symptoms
Depressive symptoms measured by the Patient Health Questionnaire - 9 (PHQ-9). The score ranges from 0 to 27, the higher the more depressed
Changes in anxiety symptoms
Anxiety symptoms measured by the Generalized Anxiety Disorder 7-item Scale (GAD-7). The score ranges from 0 to 21, the higher the more anxious
Changes in mental wellbeing
Mental well-being measured by the Warwick Edinburgh Mental Well-being Scale (WEMWBS). The score ranges from 14 to 70, the higher the greater level of mental well-being
Changes in ADHD symptoms
ADHD symptoms measured by the Adult ADHD Self-Report Scale (ASRS). The score ranges from 0 to 72, the higher the greater symptom severity
Changes in functional impairment due to ADHD symptoms
Functional impairment due to ADHD symptoms measured by three questions evaluating the extent to which individuals' ADHD symptoms affect their ability to function in the domains of work/study, housekeeping, and social relationships. The questions are rated on a 4-point scale, with higher ratings indicating higher level of impairment
Changes in executive skills
Executive skills measured by the Executive Skills Questionnaire-Revised (ESQ-R). The score ranges from 0 to 75, the lower the stronger executive skills
Full Information
NCT ID
NCT05133908
First Posted
November 22, 2021
Last Updated
February 26, 2022
Sponsor
The University of Hong Kong
1. Study Identification
Unique Protocol Identification Number
NCT05133908
Brief Title
dCBTi for Adults With ADHD
Official Title
A Randomized Controlled Trial of Digital Cognitive Behavioral Therapy for Insomnia (dCBTi) for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 21, 2022 (Actual)
Primary Completion Date
December 31, 2022 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Hong Kong
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The current study aims to evaluate the efficacy and feasibility of a digital application-based CBTi treatment devised for adults with ADHD and insomnia compared to self-monitoring and sleep hygiene control condition.
Detailed Description
Participants would be randomly assigned to the experimental or sleep diary self-monitoring (control) group. Participants in the experimental group would use a digital application for seven weeks, whereas participants in the control group would watch psychoeducation videos on sleep hygiene and enter sleep diary measures using the application for seven weeks.
Question 1:
Does dCBTi work better than the active control?
Hypothesis 1:
Improvement in insomnia (immediately after treatment and at 1-month follow-up) would be greater for the experimental group than the active control group.
Question 2:
Does improvement in insomnia due to dCBTi lead to improvement in ADHD outcomes?
Hypothesis 2:
Improvement in ADHD outcomes would be greater for the experimental group than the active control group. The effect of dCBTi on ADHD outcomes would be mediated by improvement in insomnia.
Question 3:
Does improvement in insomnia due to dCBTi lead to improvement in mental well-being?
Hypothesis 3:
Improvement in outcomes related to mental well-being would be greater for the experimental group than the active control group. The effect of dCBTi on outcomes related to mental well-being would be mediated by improvement in insomnia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia
Keywords
Digital intervention, Cognitive Behavioral Therapy for Insomnia, Treatment efficacy, Treatment adherence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
All outcome measures will be administered via online surveys
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Digital Sleep Hygiene and Self-Monitoring Control
Arm Type
Active Comparator
Arm Description
Participants assigned to this condition will receive an app to track sleep and offers sleep hygiene recommendations
Arm Title
dCBTi-ADHD
Arm Type
Experimental
Arm Description
Participants assigned to this condition will receive a 7-module digital cognitive behavioral therapy for insomnia (dCBTi) tailored for adults with ADHD
Intervention Type
Behavioral
Intervention Name(s)
Sleep Hygiene and Self-Monitoring Control
Intervention Description
An app with self-monitoring function and videos and written materials about sleep hygiene will be provided.
Intervention Type
Behavioral
Intervention Name(s)
dCBTi-ADHD
Intervention Description
The dCBTi adopts a multi-module approach, consisting of 7 weekly modules including psychoeducation on sleep and ADHD, insomnia, organization strategies and distractibility reduction skills, sleep hygiene, sleep restriction and prescription, circadian-related activity scheduling, stimulus control, relaxation and worry time, cognitive restructuring, and relapse prevention. In each module, participants will watch short videos to learn strategies to improve their sleep. A virtual coach is also included in the app functionality. It will be in the form of a text-based forced-choice conversation bot. It will initiate conversations with the users to check their understanding of treatment materials and guide them to come up with specific action plans to implement the treatment strategies.
Primary Outcome Measure Information:
Title
Changes in Insomnia Severity Index (ISI)
Description
Insomnia symptoms measured by the Insomnia Severity Index (ISI). The score ranges from 0 to 24. Higher scores indicate greater levels of insomnia symptoms
Time Frame
13 weeks from baseline
Secondary Outcome Measure Information:
Title
Changes in total sleep time (TST)
Description
Total sleep time (TST) measured by Consensus Sleep Diary. Its units is minutes. Higher TST indicates longer total sleep duration.
Time Frame
13 weeks from baseline
Title
Changes in sleep efficiency (SE)
Description
Sleep efficiency (SE) measured by Consensus Sleep Diary. It ranges from 0 to 100%, the higher indicates better sleep
Time Frame
13 weeks from baseline
Title
Changes in sleep onset latency (SOL)
Description
Sleep onset latency (SOL) measured by Consensus Sleep Diary. Its unit is minutes. Longer SOL indicates greater levels of insomnia
Time Frame
13 weeks from baseline
Title
Changes in midsleep time (MST)
Description
Midsleep time (MST) measured by Consensus Sleep Diary. Its unit is time. Earlier MST indicates earlier overall timing of sleep.
Time Frame
13 weeks from baseline
Title
Changes in fatigue
Description
Fatigue measured by the Fatigue Assessment Scale (FAS). The score ranges from 10 to 50, the higher the greater levels of fatigue
Time Frame
13 weeks from baseline
Title
Changes in depressive symptoms
Description
Depressive symptoms measured by the Patient Health Questionnaire - 9 (PHQ-9). The score ranges from 0 to 27, the higher the more depressed
Time Frame
13 weeks from baseline
Title
Changes in anxiety symptoms
Description
Anxiety symptoms measured by the Generalized Anxiety Disorder 7-item Scale (GAD-7). The score ranges from 0 to 21, the higher the more anxious
Time Frame
13 weeks from baseline
Title
Changes in mental wellbeing
Description
Mental well-being measured by the Warwick Edinburgh Mental Well-being Scale (WEMWBS). The score ranges from 14 to 70, the higher the greater level of mental well-being
Time Frame
13 weeks from baseline
Title
Changes in ADHD symptoms
Description
ADHD symptoms measured by the Adult ADHD Self-Report Scale (ASRS). The score ranges from 0 to 72, the higher the greater symptom severity
Time Frame
13 weeks from baseline
Title
Changes in functional impairment due to ADHD symptoms
Description
Functional impairment due to ADHD symptoms measured by three questions evaluating the extent to which individuals' ADHD symptoms affect their ability to function in the domains of work/study, housekeeping, and social relationships. The questions are rated on a 4-point scale, with higher ratings indicating higher level of impairment
Time Frame
13 weeks from baseline
Title
Changes in executive skills
Description
Executive skills measured by the Executive Skills Questionnaire-Revised (ESQ-R). The score ranges from 0 to 75, the lower the stronger executive skills
Time Frame
13 weeks from baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
(a) Hong Kong resident,
(b) Aged between 18-60,
(c) Diagnosed with ADHD,
(d) Able to read and write Chinese,
(e) Has regular access to a smart phone and internet,
(f) Insomnia severity index ⩾10
Exclusion Criteria:
(a) Having comorbid bipolar disorder, psychosis, suicidality, moderately severe to severe depression, narcolepsy, and/or hypersomnolence disorder,
(b) Having medical conditions that might affect sleep (e.g., serious physical concerns necessitating surgery, risk of falls, epilepsy),
(c) Having night shift schedules at work,
(d) Currently receiving psychological intervention for insomnia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wai Sze Chan, PhD
Phone
(852) 3917 2295
Email
chanwais@hku.hk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wai Sze Chan, PhD
Organizational Affiliation
The University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Hong Kong
City
Hong Kong
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wai Sze Chan, PhD
Email
slashlab@hku.hk
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Deidentified individual participant data will be made available for sharing with other researchers for secondary analysis upon request.
IPD Sharing Time Frame
From after the study findings have been published to 5 years afterwards.
IPD Sharing Access Criteria
The request party has a pre-registration of the research that requires data from the present study indicating clearly what data are required and other criteria as the PI deem appropriate.
Learn more about this trial
dCBTi for Adults With ADHD
We'll reach out to this number within 24 hrs